Orthofix Medical (OFIX) Cash & Equivalents Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Orthofix Medical | 375.38 Mn | 254.51 Mn | 139.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.93% |
| Dec 31, 2025 | -3.16% |
| Sep 30, 2025 | -4.66% |
| Jun 30, 2025 | -17.62% |
| Mar 31, 2025 | 0.07% |
| Dec 31, 2024 | 3.61% |
| Sep 30, 2024 | -11.97% |
| Jun 30, 2024 | -12.75% |
| Mar 31, 2024 | -10.39% |
| Dec 31, 2023 | -13.81% |
| Sep 30, 2023 | -9.76% |
| Jun 30, 2023 | -3.82% |
| Mar 31, 2023 | -8.30% |
| Dec 31, 2022 | 25.87% |
| Sep 30, 2022 | -0.85% |
| Jun 30, 2022 | 45.92% |
| Mar 31, 2022 | 51.54% |
| Dec 31, 2021 | 10.25% |
| Sep 30, 2021 | 12.05% |
| Jun 30, 2021 | 14.59% |
| Mar 31, 2021 | 18.87% |
| Dec 31, 2020 | 8.63% |
| Sep 30, 2020 | 4.61% |
| Jun 30, 2020 | 25.31% |
| Mar 31, 2020 | 14.16% |
| Dec 31, 2019 | 13.62% |
| Sep 30, 2019 | 13.77% |
| Jun 30, 2019 | 12.51% |
| Mar 31, 2019 | 13.19% |
| Dec 31, 2018 | 19.21% |
| Sep 30, 2018 | 22.09% |
| Jun 30, 2018 | 11.62% |
| Mar 31, 2018 | 18.57% |
| Dec 31, 2017 | -12.20% |
| Sep 30, 2017 | 0.13% |
| Jun 30, 2017 | -29.06% |
| Mar 31, 2017 | -28.17% |
| Dec 31, 2016 | 10.50% |
| Sep 30, 2016 | 10.04% |
| Jun 30, 2016 | 8.05% |
| Mar 31, 2016 | 11.25% |
| Dec 31, 2015 | 36.24% |
| Sep 30, 2015 | 33.10% |
| Jun 30, 2015 | 23.22% |
| Dec 31, 2014 | 22.53% |